Fore Biotherapeutics

About:

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Website: http://fore.bio

Twitter/X: forebiotx

Top Investors: OrbiMed, Cormorant Asset Management, Medicxi, Wellington Management, Novartis Venture Fund

Description:

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics. The company is creating a pipeline of precision oncology treatments aimed at patients with unaddressed mutations across well-established oncology targets.

Total Funding Amount:

$167M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Philadelphia, Pennsylvania, United States

Founded Date:

2011-01-01

Contact Email:

ForeBio(AT)argotpartners.com

Founders:

Matthew Ros

Number of Employees:

11-50

Last Funding Date:

2023-08-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai